Concepts (221)
Concepts are derived automatically from a person's publications.
Concepts are listed by decreasing relevance which is based on many factors, including how many publications the person wrote about that topic, how long ago those publications were written, and how many publications other people have written on that same topic.
Name |
Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
---|
Stress Disorders, Post-Traumatic | 29 | 2023 | 231 | 10.490 |
Why?
|
Veterans | 14 | 2022 | 96 | 5.860 |
Why?
|
Military Personnel | 8 | 2022 | 39 | 4.160 |
Why?
|
Sex Offenses | 6 | 2022 | 24 | 1.960 |
Why?
|
Depression | 7 | 2019 | 444 | 1.570 |
Why?
|
Homeless Youth | 3 | 2022 | 14 | 1.540 |
Why?
|
Anxiety Disorders | 10 | 2022 | 171 | 1.460 |
Why?
|
Social Support | 3 | 2021 | 196 | 1.380 |
Why?
|
Parents | 3 | 2018 | 113 | 1.330 |
Why?
|
Humans | 57 | 2023 | 27072 | 1.220 |
Why?
|
Sleep Wake Disorders | 3 | 2023 | 123 | 1.190 |
Why?
|
Depressive Disorder | 3 | 2018 | 177 | 1.160 |
Why?
|
Adult | 33 | 2023 | 7831 | 1.110 |
Why?
|
Female | 40 | 2023 | 15212 | 1.070 |
Why?
|
Male | 38 | 2023 | 14772 | 1.050 |
Why?
|
Survivors | 5 | 2022 | 70 | 1.040 |
Why?
|
Guilt | 2 | 2023 | 5 | 1.000 |
Why?
|
Shame | 2 | 2023 | 5 | 1.000 |
Why?
|
Parenting | 3 | 2018 | 72 | 0.970 |
Why?
|
Psychotherapy | 3 | 2022 | 39 | 0.900 |
Why?
|
Cognition | 6 | 2023 | 1339 | 0.900 |
Why?
|
Morals | 3 | 2020 | 13 | 0.890 |
Why?
|
Anxiety | 4 | 2022 | 156 | 0.850 |
Why?
|
Child Abuse | 1 | 2023 | 32 | 0.840 |
Why?
|
Psychiatric Status Rating Scales | 8 | 2017 | 310 | 0.830 |
Why?
|
Self Report | 3 | 2021 | 223 | 0.800 |
Why?
|
Mobile Applications | 2 | 2019 | 29 | 0.770 |
Why?
|
Mental Health Services | 2 | 2019 | 36 | 0.760 |
Why?
|
Cross-Sectional Studies | 6 | 2023 | 891 | 0.750 |
Why?
|
Crime Victims | 1 | 2022 | 32 | 0.750 |
Why?
|
Treatment Outcome | 13 | 2022 | 3485 | 0.750 |
Why?
|
Adolescent | 13 | 2022 | 2172 | 0.740 |
Why?
|
Psychometrics | 3 | 2019 | 220 | 0.730 |
Why?
|
Implosive Therapy | 3 | 2021 | 19 | 0.720 |
Why?
|
Young Adult | 9 | 2022 | 1994 | 0.700 |
Why?
|
Surveys and Questionnaires | 8 | 2019 | 1144 | 0.690 |
Why?
|
Middle Aged | 22 | 2019 | 8923 | 0.660 |
Why?
|
United States | 6 | 2023 | 2035 | 0.650 |
Why?
|
Warfare | 2 | 2016 | 12 | 0.650 |
Why?
|
Terrorism | 2 | 2016 | 9 | 0.650 |
Why?
|
Firearms | 1 | 2019 | 1 | 0.640 |
Why?
|
Wounds, Gunshot | 1 | 2019 | 3 | 0.630 |
Why?
|
Suicide | 1 | 2019 | 12 | 0.630 |
Why?
|
Phototherapy | 1 | 2019 | 30 | 0.620 |
Why?
|
Personal Satisfaction | 2 | 2016 | 43 | 0.620 |
Why?
|
Wearable Electronic Devices | 1 | 2019 | 44 | 0.600 |
Why?
|
Sleep Initiation and Maintenance Disorders | 1 | 2020 | 108 | 0.590 |
Why?
|
Occupational Diseases | 1 | 2018 | 22 | 0.590 |
Why?
|
Violence | 1 | 2017 | 39 | 0.540 |
Why?
|
Internal-External Control | 1 | 2016 | 14 | 0.540 |
Why?
|
Self Efficacy | 1 | 2016 | 53 | 0.530 |
Why?
|
Bulimia Nervosa | 2 | 2006 | 2 | 0.510 |
Why?
|
Resilience, Psychological | 1 | 2016 | 26 | 0.500 |
Why?
|
Parent-Child Relations | 2 | 2018 | 37 | 0.490 |
Why?
|
Mental Disorders | 1 | 2016 | 141 | 0.470 |
Why?
|
Child | 5 | 2023 | 1295 | 0.440 |
Why?
|
Phobic Disorders | 2 | 2013 | 66 | 0.430 |
Why?
|
Feasibility Studies | 3 | 2019 | 220 | 0.430 |
Why?
|
Pilot Projects | 3 | 2019 | 420 | 0.400 |
Why?
|
Aged | 10 | 2019 | 8997 | 0.400 |
Why?
|
Behavior Therapy | 1 | 2013 | 86 | 0.400 |
Why?
|
Students | 2 | 2011 | 48 | 0.330 |
Why?
|
Yoga | 2 | 2020 | 11 | 0.320 |
Why?
|
Psychotherapy, Group | 2 | 2019 | 40 | 0.310 |
Why?
|
Mental Health | 2 | 2022 | 108 | 0.300 |
Why?
|
Mindfulness | 2 | 2020 | 47 | 0.300 |
Why?
|
Sleep | 2 | 2023 | 328 | 0.290 |
Why?
|
Iris Diseases | 1 | 2007 | 1 | 0.280 |
Why?
|
Glaucoma, Angle-Closure | 1 | 2007 | 1 | 0.280 |
Why?
|
Iridectomy | 1 | 2007 | 1 | 0.280 |
Why?
|
Silicone Oils | 1 | 2007 | 3 | 0.280 |
Why?
|
Laser Therapy | 1 | 2007 | 11 | 0.280 |
Why?
|
Severity of Illness Index | 6 | 2020 | 879 | 0.280 |
Why?
|
Peer Group | 1 | 2006 | 35 | 0.250 |
Why?
|
Emotions | 2 | 2023 | 72 | 0.240 |
Why?
|
Qualitative Research | 2 | 2022 | 114 | 0.220 |
Why?
|
Grief | 3 | 2008 | 18 | 0.210 |
Why?
|
Bipolar Disorder | 4 | 2007 | 130 | 0.210 |
Why?
|
Combined Modality Therapy | 4 | 2013 | 300 | 0.200 |
Why?
|
Actigraphy | 1 | 2023 | 100 | 0.200 |
Why?
|
Adaptation, Psychological | 3 | 2019 | 175 | 0.200 |
Why?
|
Social Problems | 1 | 2022 | 7 | 0.200 |
Why?
|
Fluoxetine | 3 | 2008 | 34 | 0.200 |
Why?
|
Amygdala | 1 | 2022 | 39 | 0.190 |
Why?
|
Disclosure | 1 | 2022 | 13 | 0.190 |
Why?
|
Phobia, Social | 1 | 2021 | 13 | 0.180 |
Why?
|
Respiratory Sinus Arrhythmia | 1 | 2021 | 1 | 0.180 |
Why?
|
Stress, Psychological | 2 | 2018 | 235 | 0.180 |
Why?
|
Effect Modifier, Epidemiologic | 1 | 2020 | 2 | 0.180 |
Why?
|
Heuristics | 1 | 2020 | 1 | 0.170 |
Why?
|
Rumination, Cognitive | 1 | 2020 | 1 | 0.170 |
Why?
|
Panic Disorder | 4 | 2009 | 133 | 0.170 |
Why?
|
Wounds and Injuries | 1 | 2020 | 45 | 0.170 |
Why?
|
Sex Factors | 3 | 2019 | 464 | 0.170 |
Why?
|
Comorbidity | 6 | 2013 | 481 | 0.170 |
Why?
|
Circadian Rhythm | 1 | 2023 | 235 | 0.170 |
Why?
|
Child, Preschool | 2 | 2021 | 641 | 0.170 |
Why?
|
Interviews as Topic | 2 | 2018 | 132 | 0.160 |
Why?
|
United States Department of Veterans Affairs | 1 | 2019 | 8 | 0.160 |
Why?
|
Logistic Models | 2 | 2019 | 395 | 0.160 |
Why?
|
Israel | 2 | 2016 | 15 | 0.160 |
Why?
|
Text Messaging | 1 | 2019 | 13 | 0.160 |
Why?
|
Longitudinal Studies | 3 | 2020 | 1368 | 0.160 |
Why?
|
Aged, 80 and over | 3 | 2019 | 4777 | 0.160 |
Why?
|
Alcoholic Intoxication | 1 | 2019 | 8 | 0.160 |
Why?
|
Financing, Personal | 1 | 2019 | 22 | 0.160 |
Why?
|
War Exposure | 1 | 2018 | 4 | 0.150 |
Why?
|
Afghan Campaign 2001- | 1 | 2017 | 6 | 0.140 |
Why?
|
Iraq War, 2003-2011 | 1 | 2017 | 8 | 0.140 |
Why?
|
Checklist | 1 | 2017 | 33 | 0.140 |
Why?
|
Multivariate Analysis | 1 | 2018 | 329 | 0.140 |
Why?
|
Russia | 1 | 2016 | 4 | 0.130 |
Why?
|
Jews | 1 | 2016 | 4 | 0.130 |
Why?
|
Emigration and Immigration | 1 | 2016 | 14 | 0.130 |
Why?
|
Arabs | 1 | 2016 | 9 | 0.130 |
Why?
|
Suicide, Attempted | 2 | 2006 | 14 | 0.130 |
Why?
|
Social Media | 1 | 2017 | 52 | 0.130 |
Why?
|
Chicago | 1 | 2019 | 949 | 0.130 |
Why?
|
Placebos | 2 | 2013 | 65 | 0.130 |
Why?
|
Retrospective Studies | 4 | 2017 | 3538 | 0.120 |
Why?
|
Prevalence | 5 | 2014 | 443 | 0.120 |
Why?
|
Diagnostic and Statistical Manual of Mental Disorders | 5 | 2021 | 39 | 0.120 |
Why?
|
Tissue Plasminogen Activator | 2 | 2007 | 42 | 0.120 |
Why?
|
Stem Cell Transplantation | 1 | 2015 | 42 | 0.120 |
Why?
|
Reproducibility of Results | 1 | 2016 | 676 | 0.110 |
Why?
|
Neutrophils | 1 | 2015 | 104 | 0.110 |
Why?
|
Life Change Events | 1 | 2014 | 37 | 0.110 |
Why?
|
Diagnostic Self Evaluation | 1 | 2013 | 14 | 0.110 |
Why?
|
Antimetabolites | 1 | 2013 | 12 | 0.110 |
Why?
|
Alcohol Drinking | 1 | 2014 | 75 | 0.110 |
Why?
|
Cycloserine | 1 | 2013 | 26 | 0.110 |
Why?
|
Risk Factors | 1 | 2019 | 2302 | 0.100 |
Why?
|
Predictive Value of Tests | 1 | 2013 | 474 | 0.100 |
Why?
|
Body Image | 1 | 2011 | 27 | 0.090 |
Why?
|
Affect | 1 | 2011 | 60 | 0.090 |
Why?
|
Factor Analysis, Statistical | 1 | 2010 | 56 | 0.090 |
Why?
|
Models, Psychological | 1 | 2010 | 69 | 0.090 |
Why?
|
Social Environment | 1 | 2010 | 76 | 0.080 |
Why?
|
Intraocular Pressure | 2 | 2007 | 9 | 0.080 |
Why?
|
Clonazepam | 1 | 2009 | 26 | 0.080 |
Why?
|
Anticonvulsants | 1 | 2009 | 56 | 0.080 |
Why?
|
Social Behavior | 2 | 2007 | 67 | 0.080 |
Why?
|
Statistics, Nonparametric | 2 | 2006 | 125 | 0.080 |
Why?
|
Ambulatory Care | 2 | 2006 | 69 | 0.080 |
Why?
|
Stress Disorders, Traumatic | 1 | 2008 | 2 | 0.070 |
Why?
|
Incidence | 2 | 2014 | 759 | 0.070 |
Why?
|
Psychotropic Drugs | 1 | 2008 | 26 | 0.070 |
Why?
|
Antidepressive Agents, Second-Generation | 1 | 2008 | 28 | 0.070 |
Why?
|
Tonometry, Ocular | 1 | 2007 | 1 | 0.070 |
Why?
|
Triamcinolone Acetonide | 1 | 2007 | 7 | 0.070 |
Why?
|
Vitrectomy | 1 | 2007 | 10 | 0.070 |
Why?
|
Retinal Detachment | 1 | 2007 | 7 | 0.070 |
Why?
|
Dexamethasone | 1 | 2007 | 34 | 0.070 |
Why?
|
Glucocorticoids | 1 | 2007 | 68 | 0.070 |
Why?
|
Treatment Failure | 1 | 2007 | 158 | 0.070 |
Why?
|
Depressive Disorder, Major | 1 | 2007 | 100 | 0.070 |
Why?
|
Dyspnea | 1 | 2006 | 41 | 0.070 |
Why?
|
Chromosome Breakage | 1 | 2006 | 3 | 0.070 |
Why?
|
Telomere | 1 | 2006 | 8 | 0.060 |
Why?
|
Mood Disorders | 1 | 2006 | 27 | 0.060 |
Why?
|
Outpatients | 1 | 2006 | 61 | 0.060 |
Why?
|
Sleep Paralysis | 1 | 2005 | 4 | 0.060 |
Why?
|
Anti-Anxiety Agents | 1 | 2005 | 38 | 0.060 |
Why?
|
Antipsychotic Agents | 1 | 2005 | 55 | 0.060 |
Why?
|
Personality Inventory | 3 | 2008 | 73 | 0.050 |
Why?
|
Plasminogen Activators | 1 | 2002 | 1 | 0.050 |
Why?
|
Glaucoma Drainage Implants | 1 | 2002 | 1 | 0.050 |
Why?
|
Anterior Chamber | 1 | 2002 | 2 | 0.050 |
Why?
|
Glaucoma | 1 | 2002 | 4 | 0.050 |
Why?
|
Thrombolytic Therapy | 1 | 2002 | 48 | 0.050 |
Why?
|
Intestines | 1 | 2022 | 80 | 0.050 |
Why?
|
Extinction, Psychological | 1 | 2021 | 12 | 0.050 |
Why?
|
Fear | 1 | 2021 | 46 | 0.050 |
Why?
|
Frustration | 1 | 2021 | 1 | 0.050 |
Why?
|
Autonomic Nervous System | 1 | 2021 | 19 | 0.040 |
Why?
|
Pandemics | 1 | 2021 | 236 | 0.040 |
Why?
|
Health Status | 2 | 2014 | 218 | 0.040 |
Why?
|
Mothers | 1 | 2021 | 186 | 0.040 |
Why?
|
Hierarchy, Social | 1 | 2018 | 4 | 0.040 |
Why?
|
Narration | 1 | 2018 | 12 | 0.040 |
Why?
|
Drug Resistance | 2 | 2009 | 47 | 0.040 |
Why?
|
Alcoholism | 1 | 2018 | 67 | 0.040 |
Why?
|
Focus Groups | 1 | 2017 | 87 | 0.030 |
Why?
|
Aging | 1 | 2006 | 1544 | 0.030 |
Why?
|
Double-Blind Method | 2 | 2009 | 406 | 0.030 |
Why?
|
Postoperative Complications | 1 | 2002 | 916 | 0.030 |
Why?
|
Decision Making | 1 | 2018 | 223 | 0.030 |
Why?
|
Prospective Studies | 2 | 2015 | 1778 | 0.030 |
Why?
|
Transplantation, Autologous | 1 | 2015 | 161 | 0.030 |
Why?
|
Religion | 1 | 2014 | 41 | 0.030 |
Why?
|
Socioeconomic Factors | 1 | 2014 | 302 | 0.030 |
Why?
|
Analysis of Variance | 1 | 2011 | 260 | 0.020 |
Why?
|
Citalopram | 1 | 2009 | 8 | 0.020 |
Why?
|
Sertraline | 1 | 2009 | 24 | 0.020 |
Why?
|
Body Mass Index | 1 | 2011 | 458 | 0.020 |
Why?
|
Patient Dropouts | 1 | 2008 | 25 | 0.020 |
Why?
|
Diagnosis, Dual (Psychiatry) | 1 | 2007 | 5 | 0.020 |
Why?
|
Antidepressive Agents | 1 | 2008 | 97 | 0.020 |
Why?
|
Interpersonal Relations | 1 | 2008 | 101 | 0.020 |
Why?
|
Observer Variation | 1 | 2007 | 96 | 0.020 |
Why?
|
Respiratory Function Tests | 1 | 2006 | 32 | 0.020 |
Why?
|
Defense Mechanisms | 1 | 2006 | 4 | 0.020 |
Why?
|
Research Design | 1 | 2008 | 185 | 0.020 |
Why?
|
Sick Role | 1 | 2006 | 15 | 0.020 |
Why?
|
Randomized Controlled Trials as Topic | 1 | 2008 | 292 | 0.020 |
Why?
|
Cellular Senescence | 1 | 2006 | 18 | 0.020 |
Why?
|
Statistics as Topic | 1 | 2006 | 105 | 0.020 |
Why?
|
Matched-Pair Analysis | 1 | 2006 | 30 | 0.020 |
Why?
|
Models, Genetic | 1 | 2006 | 41 | 0.020 |
Why?
|
Dysthymic Disorder | 1 | 2006 | 2 | 0.020 |
Why?
|
Reference Values | 1 | 2006 | 186 | 0.020 |
Why?
|
Drug Synergism | 1 | 2005 | 40 | 0.020 |
Why?
|
Age of Onset | 1 | 2006 | 94 | 0.020 |
Why?
|
Sleep, REM | 1 | 2005 | 15 | 0.020 |
Why?
|
Benzodiazepines | 1 | 2005 | 46 | 0.020 |
Why?
|
Attention | 1 | 2006 | 124 | 0.020 |
Why?
|
Chronic Disease | 1 | 2006 | 415 | 0.010 |
Why?
|
Case-Control Studies | 1 | 2006 | 587 | 0.010 |
Why?
|
Fibrinolysis | 1 | 2002 | 6 | 0.010 |
Why?
|
Prosthesis Implantation | 1 | 2002 | 26 | 0.010 |
Why?
|
Follow-Up Studies | 1 | 2005 | 1792 | 0.010 |
Why?
|